Posters & Abstracts
We would like to thank Red Maple Trials (RMT), staff at Yang Medicine, the HAE Canada Advocacy Committee and Board of Directors, as well as HAE specialists from across Canada for the amazing job they do creating our posters and abstracts. We are grateful we can collaborate with this team of experts. These documents are developed using real world data collected from our members through our different surveys, particularly our two National Report Card surveys (2017 & 2020). Thank you to our members who complete our surveys; we are grateful to have an engaged membership.
Please click the images to view the posters and abstracts that HAE Canada presented at both national and international scientific meetings.
2023
European Academy of Allergy and Clinical Immunology (EAACI)’s Hybrid Congress in Hamburg, Germany (June)
Quality of life and measures of well being of Canadian patients with HAE based on data from the 2020 national survey.
American Academy of Allergy Asthma and Immunology (AAAAi)’s Annual Meeting in San Antonio, Texas (February)
Emergency room visits by patients with HAE based on data from the Canadian 2020 national survey
2022
HAE International 2022 Global Leadership Workshop, in Frankfurt, Germany (October)
HAE with normal C1 esterase inhibitor (HAEnC1INH): Diagnosis, treatment and attack frequency from the 2020 Canadian patient survey
Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting, in Quebec City (September)
HAE with normal C1 esterase inhibitor (HAEnC1INH): Treatment and attack frequency changes from 2017 to 2020 based on data from the Canadian national patient surveys
European Academy of Allergy and Clinical Immunology (EAACI)‘s Hybrid Congress in Prague, Czech Republic (July)
Type I/II HAE: Treatment and attack frequency improvements between 2017 and 2020 based on data from the Canadian national patient surveys
American Academy of Allergy Asthma and Immunology (AAAAi)’s Virtual Annual Meeting in Phoenix, AZ (February)
HAE with Normal C1-INH: treatment and attack frequency based on data from the Canadian 2020 National Report Card survey
2021
Canadian Society of Allergy and Clinical Immunology (CSACI)‘s Virtual Scientific Meeting (September)
HAE in Canada: Changes in medication use and untreated attacks between 2017 and 2020 surveys.
European Academy of Allergy and Clinical Immunology (EAACI)‘s Hybrid Congress in Madrid & Krakow (July)
HAE in Canada: Preliminary demographic and treatment results from the second national survey
AAAAi’s Virtual Annual Meeting (February)
Real World Data of Canadians living with angioedema: Health Economic Burden
2020
Japanese Society of Allergology (JSA) / World Allergy Organization (WAO) Joint Congress 2020 (October) *
Assessment of HAE-specific quality of life and proximity to acute therapy & Prodromes and attack triggers in Canadian HAE patients
EAACI Digital Congress (June) **
Real world data of Canadians living with HAE: Need for innovative, newer prophylactic and subcutaneous medications
HAE International (HAEi)’s HAE Global Virtual Conference (May)
Fear of Attacks Reduces Quality of Life for Canadian HAE Patients
* in collaboration with the Canadian HAE Network (CHAEN)
** This poster was awarded a Five Star Rating by Dr. Marcus Maurer at the EAACI Digital Congress